| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2928036 | Indian Heart Journal | 2012 | 5 Pages |
Abstract
Dronedarone is a newer therapeutic agent with a structural resemblance to amiodarone and a better side effect profile. It is a multichannel blocker with antiadrenergic properties and has been evaluated in both rate and rhythm control strategies in the management of AF. In this review, we discuss the current role of dronedarone in the contemporary management of AF.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Gajendra Manakshe, B. Hygriv Rao,